An Important Message Re: Effer-k's Response to COVID-19

Dear Effer-k Customer:

With the ever-changing impact that COVID-19 is having on our lives, we wanted to give a quick update on what Effer-k is doing to keep our employees and customers safe and healthy during this critical time.

Effer-K is following the guidelines of the US Centers for Disease Control (CDC) and the World Health Organization (WHO) on preventing the spread of COVID-19. The majority of our sales reps and office staff are now working from home. For those employees who must be in the office, we are taking body temperatures before entering the building, practicing social distancing and have added a number of hand sanitizing stations throughout our facility. We have also increased the cleaning staff and the frequency of disinfection. On our manufacturing side, we have created shifts to keep the number of people in the building to the necessary minimum. To date, we haven't had any occurrences, and there are no employee cases of COVID-19.

We are closely monitoring this situation, and will remain open as long as possible to meet your business needs. Currently, we are still processing and shipping orders daily. Where supply chains have been interrupted on high demand products, we have implemented limits to try and insure availability for the largest number of our customers for as long as possible.

We will keep you updated on any changes.

Charlies Voellinger, Jr
President, Effer-k.
For any questions or concerns, please contact us.

Effer-K® Potassium Citrate

Effer-K®, effervescent potassium bicarbonate / citric acid which effervesces to form potassium citrate in a liquid form in 10 mEq, 20 mEq and 25 mEq strengths.

View all Effer-K® Prescribing Information

State Drug Cards

Effer-K® is covered on all state discount drug card programs.

Learn More

Effer-K®, potassium citrate, offers patients many benefits

Home | About | Clinical Studies | Testimonials | FAQ | Ordering Info | Blog | Contact Us

Manufactured by Nomax Inc. Made in the USA

Warning: In patients with hyperkalemia and impaired mechanisms for excreting potassium, the administration of potassium salts can produce hyperkalemia and cardiac arrest.

Note: Effer-K is not equivalent to KCl. It is potassium citrate in solution, not potassium chloride. While potassium citrate can be used to elevate potassium levels, it is not recommended for patients who have metabolic alkalosis or acid/base disorders. It may result in the alteration of the acid/base balance.